Biotechnology
Investing News
Market News
Technology
Novavax Awarded Department of Defense Contract for a Pssoble COVID-19 Vaccine
Novavax, Inc. (NASDAQ: NVAX) announced Thursday that it has been awarded a contract by the U.S. Department of Defense (DoD) for the manufacturing of NVX‑CoV2373, Novavax’ COVID-19 vaccine candidate....